Financials
- Market Capitalization 269.41 M
- Employee 56
- Founded 2018
- CEO N/A
- Website www.pyxisoncology.com
- Headquarter Delaware, United States
- FIGI BBG00PQFFCV5
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3413 | ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 3.80 USD | -2.06% | -1.55% | -20.50% | +123.53% | 272.35 M USD | ||
| 3419 | ACIU AC Immune SA - Common Stock | 2.65 USD | -2.21% | -8.93% | +15.22% | +27.40% | 269.62 M USD | ||
| 3427 | SION Sionna Therapeutics, Inc. - Common Stock | 5.87 USD | -3.14% | +11.17% | -86.87% | -85.08% | 265.40 M USD | ||
| 3431 | SRZN Surrozen, Inc. - Common Stock | 22.42 USD | -6.62% | -4.39% | +16.47% | +86.37% | 263.51 M USD |
Frequently asked questions about Pyxis Oncology, Inc. Common Stock
What is the Pyxis Oncology, Inc. Common Stock stock price today?
The current price of Pyxis Oncology, Inc. Common Stock (PYXS) is 3.23. Over the past 24 hours, the stock has changed by -2.71%. Follow the PYXS chart for real-time price dynamics.
What is the stock ticker of Pyxis Oncology, Inc. Common Stock?
Pyxis Oncology, Inc. Common Stock trades under the ticker PYXS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Pyxis Oncology, Inc. Common Stock stock going up?
PYXS has changed by +6.95% over the last week, +9.49% over the last month, and +152.34% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Pyxis Oncology, Inc. Common Stock?
Pyxis Oncology, Inc. Common Stock currently has a market capitalization of 269.41 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Pyxis Oncology, Inc. Common Stock earnings last quarter?
Last quarter, Pyxis Oncology, Inc. Common Stock reported earnings of -0.4 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Pyxis Oncology, Inc. Common Stock revenue for the last quarter?
Pyxis Oncology, Inc. Common Stock reported quarterly revenue of 389 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Pyxis Oncology, Inc. Common Stock net income for the last quarter?
Pyxis Oncology, Inc. Common Stock reported net income of -25.35 M for the last quarter. The previous quarter showed -23.27 M, which means net income changed by -8.91%.
How many employees does Pyxis Oncology, Inc. Common Stock have?
As of the latest available data, Pyxis Oncology, Inc. Common Stock has 56 employees. Workforce size can provide additional context about the company's scale and operations.
What is Pyxis Oncology, Inc. Common Stock EBITDA?
Pyxis Oncology, Inc. Common Stock EBITDA is -25.3 M, and its EBITDA margin is -6 503.86%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Pyxis Oncology, Inc. Common Stock stock?
You can buy Pyxis Oncology, Inc. Common Stock (PYXS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Pyxis Oncology, Inc. Common Stock stock?
Investing in Pyxis Oncology, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PYXS chart and related analysis on metatrader.com as part of your research.